Price $66.75 |
Market Cap
762.4M
|
Sector Health Care |
Div. Growth
-22.80%
|
|
P/E
36.7
|
P/B
3.96
|
P/S
2.12
|
Dividend %
1.30%
|
|
P/CF
300.6
|
P/FCF
29.9
|
Op. Cash Flow
36K
|
FCF
2.0
|
|
Op. Margin
14.10%
|
Net Margin
5.60%
|
ROE
11.00%
|
ROI
15.70%
|
|
ROA
5.90%
|
EPS Growth
-36.00%
|
Current Ratio
2.7
|
Debt/Equity
27.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.37 | - | - | 91.5M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.28 | - | - | 30.8M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.48 | - | - | 4M | Strong Buy |
| Birner Dental Mgmt Services In (BDMS) | $12.25 | - | 6.50% | 25.1M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.55 | - | - | 1.27B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
